Bay Regional Medical Center Installs "Mini-Pump" To Assist Ailing Heart
Bay Regional Medical Center announced today the completion of its first procedure with Abiomed’s Impella 2.5 heart pump for commercial use. Cardiologist Stephen Mattichak, MD performed the procedure on a 59-year-old Northeast Michigan man on October 15. Bay Regional can now add the world’s smallest heart pump to their portfolio of treatment options to assist critically ill patients that are experiencing advanced cardiac failure or shock in recovering from heart attack or other injury.
As the smallest FDA approved heart pump on the market, Impella 2.5 works by temporarily relieving the heart’s pumping function and providing the time needed to initiate life-saving interventions. The patient received the pump through a small groin incision, in a procedure lasting less than fifteen minutes. He required the assistive device due to heart problems that were unable to be remedied through more traditional heart surgery or catheterization procedures.
Impella 2.5 is inserted through an artery in the leg in the catheterization laboratory (cath lab) via the femoral artery into the left ventricle. Up to two and a half liters of blood are delivered by the pump from the left ventricle into the ascending aorta, providing the heart with active support five times faster than current industry devices and three to five times more blood flow than the present standard of care.
With more than 700 U.S. hospitals currently using Impella 2.5, Bay Regional adds to the growing number of healthcare institutions that are committed to optimal heart recovery and understand the importance in enabling patients to return home.
“Our team can now perform cutting-edge, life-saving cardiovascular procedures in a matter of minutes,” said Stephen Mattichak, M.D., Interventional Cardiologist with Bay Regional Heart and Vascular. “Impella 2.5 is a breakthrough technology that offers our physicians a minimally invasive approach in cardiac treatment and will help change the standard of care in the cath lab with immediate circulatory support for critical patients.”
About the Impella 2.5
Abiomed’s Impella 2.5 is a cardiac assist device which is inserted percutaneously in the cardiac catheterization lab, providing patients with up to 2.5 liters of blood flow per minute. It is the world's smallest heart pump and has been used to treat conditions such as acute myocardial infarction (heart attack), cardiogenic shock and low output syndrome.
Due to a rise in conditions such as triple vessel disease in patients with poor cardiac function, which is caused by coronary vessel blocks in three vessels of the heart, the Impella 2.5 provides a new treatment option that aims to improve patient outcomes. The Impella 2.5 can be quickly inserted into the left ventricle through the femoral artery, into the ascending aorta, across the valve and into the left ventricle and can remain in place for short-term support. Now being used in over 700 hospitals in the U.S., the Impella 2.5 is approved in more than 40 countries, including in Europe under the CE Mark. The Impella platform has been used to treat more than 1,900 patients outside the U.S. and has been the subject of more than 50 peer reviewed publications.
Bay Regional Medical Center (BRMC) is a 404-bed acute care hospital in Bay City, Michigan serving Bay County and other counties to the north and east. After merging four hospitals during the 1970s and 1980s, Bay Regional Medical Center developed a full continuum of health services for Northeast Michigan. With acute care at Bay Regional Medical Center, more than 2,000 employees provide quality care to nearly a half million people in the Great Lakes Bay Region. BRMC is a subsidiary of McLaren Health Care (MHC), a fully integrated health care delivery system committed to meeting the health care needs of mid-Michigan residents and to enhancing their health status. The mission of MHC is to be Michigan’s best value in healthcare as defined by quality outcomes and cost. McLaren Health Care is annually ranked by Verispan among the top 100 Integrated Health Systems in the United States, most recently receiving the ranking of 14th best.
About Abiomed
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.
